Lifestyle Intervention in Patients With New Onset Type 2 Diabetes.

The study seeks to establish if weight loss achieved through a program of intensive lifestyle management can result in improvements in GLP-1 and glycaemic control, in patients with newly diagnosed type 2 diabetes mellitus.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Type 2 Diabetes Diabetes Mellitus Diabetes Mellitus, Type 2 Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

New onset type 2 Diabetes
Body mass index 25 and above
Able to give informed consent

Exclusion criteria

Hypoglycaemic and antiobesity agents, or any other prescription medication that may interfere with study results

Treatment and study plan

Group lifestyle programme

Behavioral

Primary outcomes

Lifestyle impact on GLP-1, HbA1c and fasting glycaemia.

Time frame: 8 months following commencement of study.

Sponsors and collaborators

Lead sponsor

The Royal Bournemouth Hospital

Other

Registry information

Official study title

Effect of Intensive Lifestyle Intervention on Hormonal Factors Regulating Food Intake and Blood Glucose Control in Patients With New Onset Type 2 Diabetes.

Important dates

Study start: 2007
Primary completion: 2010
Study completion: 2010
First posted: Jul 26, 2011
Registry last updated: Jul 26, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed